Prevalence, Factors, and Impact of CKD-aP on Quality of Life and Sleep in Indian Hemodialysis Patients: Cross-Sectional Study
Kidney and Dialysis · 12.05.2026 · 6 (2) · 32
DOI: 10.3390/kidneydial6020032 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Kidney and Dialysis, online erschienen am 12.05.2026. Verfasst von Shreya Jain und 8 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic kidney disease-associated pruritus (CKD-aP) is characterised as pruritus in individuals with advanced chronic kidney disease (CKD) without a discernible alternative etiology. This study assessed the prevalence, severity, and effects of CKD-aP on sleep and health-related quality of life (HRQoL) among end-stage kidney disease patients (ESKD) undergoing maintenance hemodialysis (MHD) in an Indian cohort.
Methods
This cross-sectional, single-centre study included adults with renal failure undergoing MHD for ≥3 months. The primary outcome was CKD-aP prevalence and its relationship with demographic, clinical, and laboratory variables. Secondary outcomes included CKD-aP severity, characteristics, HRQoL, and sleep quality scores. Statistical analysis was conducted using SPSS v21, with a significance level of p < 0.05.
Results
The 12-item Pruritus Severity Scale found mild CKD-aP to be the most common (37% of patients). The 5-D Itch Scale found that patients with moderate-to-severe CKD-aP had longer daily itching (52.9%) with a nonsignificant change over time (p = 0.18), and the back (77.9%) was the most affected site. The Dermatology Life Quality Index revealed that 75.5% of patients had HRQoL impairment. The Skindex-16 found that moderate-to-severe CKD-aP was linked to a greater symptom burden and emotional distress. The Pittsburgh Sleep Quality Index found poorer sleep quality as CKD-aP worsened.
Conclusions
CKD-aP is common in patients undergoing hemodialysis and negatively impacts quality of life, emphasizing the need for routine assessment and targeted management.
Zitieren
APA
Jain, S., Nagaraju, S. P., Rani, P., Bhojaraja, M. V., Shirodkar, S. N. S., Prabhu, A. R., Rangaswamy, D., Rao, I. R., & Shenoy, S. V. (2026). Prevalence, Factors, and Impact of CKD-aP on Quality of Life and Sleep in Indian Hemodialysis Patients: Cross-Sectional Study. Kidney and Dialysis, 6(2), 32. https://doi.org/10.3390/kidneydial6020032
Vancouver
Jain S, Nagaraju SP, Rani P, Bhojaraja MV, Shirodkar SNS, Prabhu AR, et al. Prevalence, Factors, and Impact of CKD-aP on Quality of Life and Sleep in Indian Hemodialysis Patients: Cross-Sectional Study. Kidney and Dialysis. 2026;6(2):32. doi:10.3390/kidneydial6020032
BibTeX
@article{Jain2026,
author = {Jain, Shreya and Nagaraju, Shankar Prasad and Rani, Priya and Bhojaraja, Mohan Varadanayakanahalli and Shirodkar, Shriya Narendra Shet and Prabhu, Attur Ravindra and Rangaswamy, Dharshan and Rao, Indu Ramachandra and Shenoy, Srinivas Vinayak},
title = {Prevalence, Factors, and Impact of CKD-aP on Quality of Life and Sleep in Indian Hemodialysis Patients: Cross-Sectional Study},
journal = {Kidney and Dialysis},
year = {2026},
volume = {6},
number = {2},
pages = {32},
doi = {10.3390/kidneydial6020032}
}
EUVIMED